• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生肿瘤坏死因子的间充质干细胞在对基于氟达拉滨的化疗耐药的慢性B淋巴细胞肿瘤细胞凋亡中的作用

Role of Tumor Necrosis Factor-Producing Mesenchymal Stem Cells on Apoptosis of Chronic B-lymphocytic Tumor Cells Resistant to Fludarabine-based Chemotherapy.

作者信息

Valizadeh Armita, Ahmadzadeh Ahmad, Saki Ghasem, Khodadadi Ali, Teimoori Ali

机构信息

Physiology Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(18):8533-9. doi: 10.7314/apjcp.2015.16.18.8533.

DOI:10.7314/apjcp.2015.16.18.8533
PMID:26745113
Abstract

BACKGROUND

B-cell chronic lymphocytic leukemia B (B-CLL), the most common type of leukemia, may be caused by apoptosis deficiency in the body. Adipose tissue-derived mesenchymal stem cells (AD-MSCs) as providers of pro-apoptotic molecules such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), can be considered as an effective anti-cancer therapy candidate. Therefore, in this study we assessed the role of tumor necrosis factor-producing mesenchymal stem cells oin apoptosis of B-CLL cells resistant to fludarabine- based chemotherapy.

MATERIALS AND METHODS

In this study, after isolation and culture of AD-MSCs, a lentiviral LeGO-iG2-TRAIL-GFP vector containing a gene producing the ligand pro-apoptotic with plasmid PsPAX2 and PMDG2 virus were transfected into cell-lines to generate T293HEK. Then, T293HEK cell supernatant containing the virus produced after 48 and 72 hours was collected, and these viruses were transduced to reprogram AD-MSCs. Apoptosis rates were separately studied in four groups: group 1, AD-MSCs-TRAIL; group 2, AD-MSCs-GFP; group 3, AD-MSCs; and group 4, CLL.

RESULTS

Observed apoptosis rates were: group 1, 42 ± 1.04%; group 2, 21 ± 0.57%; group 3, 19± 2.6%; and group 4, % 0.01 ± 0.01. The highest rate of apoptosis thus occurred ingroup 1 (transduced TRAIL encoding vector). In this group, the average medium-soluble TRAIL was 72.7pg/m and flow cytometry analysis showed a pro-apoptosis rate of 63 ± 1.6%, which was again higher than in other groups.

CONCLUSIONS

In this study we have shown that tumor necrosis factor (TNF) secreted by AD-MSCs may play an effective role in inducing B-CLL cell apoptosis.

摘要

背景

B 细胞慢性淋巴细胞白血病 B(B-CLL)是最常见的白血病类型,可能由机体凋亡缺陷引起。脂肪组织来源的间充质干细胞(AD-MSCs)作为促凋亡分子如肿瘤坏死因子相关凋亡诱导配体(TRAIL)的提供者,可被视为一种有效的抗癌治疗候选者。因此,在本研究中,我们评估了产生肿瘤坏死因子的间充质干细胞在对基于氟达拉滨的化疗耐药的 B-CLL 细胞凋亡中的作用。

材料与方法

在本研究中,分离培养 AD-MSCs 后,将含有产生促凋亡配体基因的慢病毒 LeGO-iG2-TRAIL-GFP 载体与质粒 PsPAX2 和 PMDG2 病毒转染到细胞系中以生成 T293HEK。然后,收集 48 小时和 72 小时后产生的含病毒的 T293HEK 细胞上清液,并将这些病毒转导以重编程 AD-MSCs。在四组中分别研究凋亡率:第 1 组,AD-MSCs-TRAIL;第 2 组,AD-MSCs-GFP;第 3 组,AD-MSCs;第 4 组,CLL。

结果

观察到的凋亡率为:第 1 组,42±1.04%;第 2 组,21±0.57%;第 3 组,19±2.6%;第 4 组,0.01±0.01%。因此,凋亡率最高的是第 1 组(转导编码 TRAIL 的载体)。在该组中,平均培养基可溶性 TRAIL 为 72.7pg/ml,流式细胞术分析显示促凋亡率为 63±1.6%,再次高于其他组。

结论

在本研究中我们表明,AD-MSCs 分泌的肿瘤坏死因子(TNF)可能在诱导 B-CLL 细胞凋亡中发挥有效作用。

相似文献

1
Role of Tumor Necrosis Factor-Producing Mesenchymal Stem Cells on Apoptosis of Chronic B-lymphocytic Tumor Cells Resistant to Fludarabine-based Chemotherapy.产生肿瘤坏死因子的间充质干细胞在对基于氟达拉滨的化疗耐药的慢性B淋巴细胞肿瘤细胞凋亡中的作用
Asian Pac J Cancer Prev. 2015;16(18):8533-9. doi: 10.7314/apjcp.2015.16.18.8533.
2
Effects of TNF secreting HEK cells on B lymphocytes' apoptosis in human chronic lymphocytic leukemias.分泌肿瘤坏死因子的人胚肾细胞对人慢性淋巴细胞白血病中B淋巴细胞凋亡的影响
Asian Pac J Cancer Prev. 2014;15(22):9885-9. doi: 10.7314/apjcp.2014.15.22.9885.
3
Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.TRAIL/APO2-L 死亡受体在苯丁酸氮芥和氟达拉滨诱导慢性淋巴细胞白血病细胞凋亡中的作用
Oncogene. 2003 Nov 13;22(51):8356-69. doi: 10.1038/sj.onc.1207004.
4
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.慢性淋巴细胞白血病(CLL)肿瘤B细胞与间充质基质细胞(MSC)之间的相互作用:对肿瘤细胞存活的影响
Oncotarget. 2015 Dec 8;6(39):42130-49. doi: 10.18632/oncotarget.6239.
5
CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.CD40激活通过自分泌肿瘤坏死因子-α和干扰素-γ以及上调肿瘤坏死因子受体-I-II增强氟达拉滨诱导的慢性淋巴细胞白血病B细胞凋亡。
Haematologica. 2003 Feb;88(2):148-58.
6
Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.通过静脉注射肿瘤坏死因子相关的凋亡诱导配体工程化人间充质干细胞对脑干胶质瘤产生双靶点抗肿瘤作用。
Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.
7
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.表达 TRAIL 的脂肪间充质干细胞的体外抗骨髓瘤活性。
Br J Haematol. 2012 Jun;157(5):586-98. doi: 10.1111/j.1365-2141.2012.09082.x. Epub 2012 Mar 16.
8
Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.间充质基质细胞递送全长肿瘤坏死因子相关凋亡诱导配体在癌症治疗方面优于可溶性形式。
Cytotherapy. 2015 Jul;17(7):885-96. doi: 10.1016/j.jcyt.2015.03.603. Epub 2015 Apr 14.
9
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.TRAIL在B细胞慢性淋巴细胞白血病(B-CLL)细胞中的异常表达。
J Cell Physiol. 2005 Nov;205(2):246-52. doi: 10.1002/jcp.20392.
10
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells.工程化脂肪间充质基质细胞释放的可溶性肿瘤坏死因子相关凋亡诱导配体对白细胞的影响。
Cytotherapy. 2023 Jun;25(6):605-614. doi: 10.1016/j.jcyt.2023.02.008. Epub 2023 Apr 1.

引用本文的文献

1
Interplay between inflammatory tumor microenvironment and cancer stem cells.炎症性肿瘤微环境与癌症干细胞之间的相互作用。
Oncol Lett. 2018 Jul;16(1):679-686. doi: 10.3892/ol.2018.8716. Epub 2018 May 16.